XML 28 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jan. 02, 2021
Dec. 28, 2019
Dec. 29, 2018
Cash flow from operating activities:      
Net income $ 141,240 $ 61,123 $ 36,330
Adjustments to reconcile net income to net cash used in operating activities:      
Depreciation, depletion, amortization and accretion 227,817 222,862 208,772
Share-based compensation expense 28,857 20,403 25,378
Net gain on asset disposals (7,548) (10,294) (30,093)
Non-cash loss on debt financings 4,064 2,850 0
Change in deferred tax asset, net (18,384) 16,012 57,490
Other 619 (2,135) 2,018
Decrease (increase) in operating assets, net of acquisitions and dispositions:      
Accounts receivable, net 5,467 (37,049) (5,796)
Inventories 3,339 8,582 (11,598)
Costs and estimated earnings in excess of billings 4,535 5,558 (8,702)
Other current assets 472 5,465 (7,159)
Other assets 10,264 5,085 (106)
(Decrease) increase in operating liabilities, net of acquisitions and dispositions:      
Accounts payable (4,231) 18,903 (13,403)
Accrued expenses 15,476 7,640 (16,544)
Billings in excess of costs and estimated earnings 2,616 1,988 (5,052)
Tax receivable agreement liability (5,285) 17,291 (21,666)
Other liabilities (449) (7,100) (501)
Net cash provided by operating activities 408,869 337,184 209,368
Cash flow from investing activities:      
Acquisitions, net of cash acquired (123,477) (5,392) (246,017)
Purchases of property, plant and equipment (177,249) (177,495) (220,685)
Proceeds from the sale of property, plant and equipment 14,018 21,173 21,635
Proceeds from sale of business 0 0 21,564
Other 1,121 (1,095) 3,804
Net cash used in investing activities (285,587) (162,809) (419,699)
Cash flow from financing activities:      
Proceeds from debt issuances 700,000 300,000 64,500
Debt issuance costs (9,605) (6,312) (550)
Payments on debt (674,045) (270,229) (85,042)
Payments on acquisition-related liabilities (33,257) (33,883) (36,504)
Distributions from partnership 0 0 (69)
Proceeds from stock option exercises 1,043 19,076 15,615
Other (907) (502) (1,943)
Net cash (used in) provided by financing activities (16,771) 8,150 (43,993)
Impact of foreign currency on cash 351 286 (724)
Net increase in cash 106,862 182,811 (255,048)
Cash and cash equivalents—beginning of period 311,319 128,508 383,556
Cash and cash equivalents—end of period 418,181 311,319 128,508
Summit Materials, LLC      
Cash flow from operating activities:      
Net income 120,737 88,597 63,837
Adjustments to reconcile net income to net cash used in operating activities:      
Depreciation, depletion, amortization and accretion 227,513 222,341 208,055
Share-based compensation expense 28,857 20,403 25,378
Net gain on asset disposals (7,548) (10,294) (30,093)
Non-cash loss on debt financings 4,064 2,850 0
Change in deferred tax asset, net (2,862) 6,350 9,729
Other 619 (2,135) 2,018
Decrease (increase) in operating assets, net of acquisitions and dispositions:      
Accounts receivable, net 5,467 (37,049) (5,796)
Inventories 3,339 8,582 (11,598)
Costs and estimated earnings in excess of billings 4,535 5,558 (8,702)
Other current assets 472 5,465 (7,159)
Other assets 10,264 5,085 (106)
(Decrease) increase in operating liabilities, net of acquisitions and dispositions:      
Accounts payable (4,231) 18,208 (13,989)
Accrued expenses 15,476 8,335 (16,653)
Billings in excess of costs and estimated earnings 2,616 1,988 (5,052)
Other liabilities (449) (7,100) (501)
Net cash provided by operating activities 408,869 337,184 209,368
Cash flow from investing activities:      
Acquisitions, net of cash acquired (123,477) (5,392) (246,017)
Purchases of property, plant and equipment (177,249) (177,495) (220,685)
Proceeds from the sale of property, plant and equipment 14,018 21,173 21,635
Proceeds from sale of business 0 0 21,564
Other 1,121 (1,095) 3,804
Net cash used in investing activities (285,587) (162,809) (419,699)
Cash flow from financing activities:      
Capital contributions by member 1,043 19,076 15,615
Proceeds from debt issuances 700,000 300,000 64,500
Debt issuance costs (9,605) (6,312) (550)
Payments on debt (674,045) (270,229) (85,042)
Payments on acquisition-related liabilities (30,757) (31,383) (34,004)
Distributions from partnership (2,500) (2,500) (2,569)
Other (907) (502) (1,943)
Net cash (used in) provided by financing activities (16,771) 8,150 (43,993)
Impact of foreign currency on cash 351 286 (724)
Net increase in cash 106,862 182,811 (255,048)
Cash and cash equivalents—beginning of period 311,319 128,508 383,556
Cash and cash equivalents—end of period $ 418,181 $ 311,319 $ 128,508